Wolverine Trading’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.4M | Buy |
201,300
+2,900
| +1% | +$229K | 0.01% | 777 |
|
|
2025
Q2 | $17.1M | Sell |
198,400
-22,000
| -10% | -$1.72M | 0.02% | 520 |
|
|
2025
Q1 | $14.9M | Buy |
220,400
+9,400
| +4% | +$767K | 0.02% | 500 |
|
|
2024
Q4 | $16.5M | Buy |
211,000
+30,900
| +17% | +$2.29M | 0.02% | 547 |
|
|
2024
Q3 | $12.1M | Buy |
180,100
+78,700
| +78% | +$6.46M | 0.01% | 605 |
|
|
2024
Q2 | $11.5M | Sell |
101,400
-10,100
| -9% | -$1.28M | 0.01% | 585 |
|
|
2024
Q1 | $15.5M | Sell |
111,500
-200
| -0.2% | -$25.1K | 0.02% | 490 |
|
|
2023
Q4 | $13.9M | Buy |
111,700
+23,200
| +26% | +$2.37M | 0.01% | 586 |
|
|
2023
Q3 | $8.26M | Sell |
88,500
-900
| -1% | -$101K | 0.01% | 712 |
|
|
2023
Q2 | $11.4M | Buy |
89,400
+5,700
| +7% | +$689K | 0.01% | 548 |
|
|
2023
Q1 | $9.57M | Sell |
83,700
-11,600
| -12% | -$1.3M | 0.01% | 559 |
|
|
2022
Q4 | $10.8M | Sell |
95,300
-42,800
| -31% | -$4.7M | 0.02% | 586 |
|
|
2022
Q3 | $11.3M | Buy |
138,100
+39,300
| +40% | +$3.33M | 0.02% | 515 |
|
|
2022
Q2 | $7.45M | Buy |
98,800
+4,000
| +4% | +$365K | 0.01% | 637 |
|
|
2022
Q1 | $12.3M | Sell |
94,800
-184,000
| -66% | -$20.1M | 0.02% | 605 |
|
|
2021
Q4 | $37.7M | Sell |
278,800
-58,400
| -17% | -$8.39M | 0.04% | 298 |
|
|
2021
Q3 | $46M | Buy |
337,200
+95,600
| +40% | +$12.1M | 0.05% | 248 |
|
|
2021
Q2 | $25.8M | Buy |
241,600
+37,200
| +18% | +$3.57M | 0.04% | 335 |
|
|
2021
Q1 | $17.7M | Sell |
204,400
-220,400
| -52% | -$20.7M | 0.03% | 439 |
|
|
2020
Q4 | $38.5M | Buy |
424,800
+88,000
| +26% | +$7.86M | 0.06% | 214 |
|
|
2020
Q3 | $33.9M | Buy |
336,800
+45,200
| +16% | +$4.72M | 0.08% | 165 |
|
|
2020
Q2 | $29M | Buy |
291,600
+139,200
| +91% | +$12.5M | 0.08% | 162 |
|
|
2020
Q1 | $10.6M | Sell |
152,400
-79,200
| -34% | -$4.93M | 0.03% | 407 |
|
|
2019
Q4 | $12.5M | Buy |
+231,600
| New | +$11M | 0.03% | 576 |
|
|
2019
Q3 | – | Sell |
-307,600
| Closed | -$11.5M | – | 4471 |
|
|
2019
Q2 | $11.5M | Sell |
307,600
-89,200
| -22% | -$2.8M | 0.03% | 470 |
|
|
2019
Q1 | $11.8M | Buy |
396,800
+284,800
| +254% | +$10M | 0.03% | 435 |
|
|
2018
Q4 | $3.31M | Sell |
112,000
-75,200
| -40% | -$2.39M | 0.01% | 1070 |
|
|
2018
Q3 | $6.69M | Buy |
187,200
+100,400
| +116% | +$3.11M | 0.01% | 782 |
|
|
2018
Q2 | $1.61M | Hold |
86,800
| – | – | ﹤0.01% | 1787 |
|
|
2018
Q1 | $1.61M | Sell |
86,800
-18,000
| -17% | -$266K | ﹤0.01% | 1787 |
|
|
2017
Q4 | $1.5M | Sell |
104,800
-37,600
| -26% | -$489K | 0.01% | 1772 |
|
|
2017
Q3 | $1.74M | Buy |
142,400
+104,000
| +271% | +$1.84M | 0.01% | 1431 |
|
|
2017
Q2 | $703K | Buy |
+38,400
| New | +$709K | ﹤0.01% | 2090 |
|
|
2017
Q1 | – | Sell |
-62,400
| Closed | -$931K | – | 4411 |
|
|
2016
Q4 | $931K | Sell |
62,400
-10,800
| -15% | -$191K | ﹤0.01% | 1973 |
|
|
2016
Q3 | $1.61M | Sell |
73,200
-51,600
| -41% | -$1.15M | 0.01% | 1464 |
|
|
2016
Q2 | $2.46M | Buy |
+124,800
| New | +$2.12M | 0.01% | 972 |
|
Other funds holding DXCM
N
Wolverine Trading's DXCM Position: Q3 2025 in Review
Wolverine Trading increased its DexCom (DXCM) stake by 165% in Q3 2025, buying an estimated $4.1M and bringing the position to 83,167 shares worth $5.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1321.
Wolverine Trading first reported a position in DXCM in Q4 2016 and has held it in 28 quarters since. The position peaked at $30.6M in Q3 2021. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.
- Wolverine Trading held 83,167 shares of DexCom worth $5.53M as of Q3 2025.
- Wolverine Trading bought 51,783 DexCom shares in Q3 2025, an estimated $4.1M.
- DexCom made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1321 holding.
- Wolverine Trading first reported a position in DexCom in Q4 2016 and has held it in 28 quarters since.
- Wolverine Trading's DexCom position peaked at $30.6M in Q3 2021.
- 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.